Cognetivity Neurosciences Ltd
Cognetivity Neurosciences Ltd. operates as a technology company. It develops an integrated cognitive assessment, a cognitive testing platform for use in medical, commercial, and consumer environments that allows early diagnosis of dementia; and OptiMind, a wellness app. The company was formerly known as Utor Capital Corp. and changed its name to Cognetivity Neurosciences Ltd. in December 2017. Co… Read more
Cognetivity Neurosciences Ltd (CGNSF) - Total Liabilities
Latest total liabilities as of October 2023: $15.68 Million USD
Based on the latest financial reports, Cognetivity Neurosciences Ltd (CGNSF) has total liabilities worth $15.68 Million USD as of October 2023.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Cognetivity Neurosciences Ltd - Total Liabilities Trend (2016–2023)
This chart illustrates how Cognetivity Neurosciences Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Cognetivity Neurosciences Ltd Competitors by Total Liabilities
The table below lists competitors of Cognetivity Neurosciences Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Pengana Private Equity Trust
AU:PE1
|
Australia | AU$15.18 Million |
|
SCIENT DIGIT IMAG
BE:SD0
|
Germany | €36.23 Million |
|
Future Generation Global Ltd
AU:FGG
|
Australia | AU$62.75 Million |
|
Watkin Jones PLC
LSE:WJG
|
UK | GBX187.44 Million |
Liability Composition Analysis (2016–2023)
This chart breaks down Cognetivity Neurosciences Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.02 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.03 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 32.23 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Cognetivity Neurosciences Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Cognetivity Neurosciences Ltd (2016–2023)
The table below shows the annual total liabilities of Cognetivity Neurosciences Ltd from 2016 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-01-31 | $12.72 Million | +65.61% |
| 2022-01-31 | $7.68 Million | +695.97% |
| 2021-01-31 | $964.89K | -4.57% |
| 2020-01-31 | $1.01 Million | +326.78% |
| 2019-01-31 | $236.91K | -35.28% |
| 2018-01-31 | $366.05K | +118.01% |
| 2017-01-31 | $167.90K | +36.43% |
| 2016-01-31 | $123.07K | -- |